A trial of clenbuterol in bronchial asthma.
Clenbuterol is a beta 2-sympathomimetic bronchodilator. In a double-blind cross-over trial in 19 asthmatic patients with reversible airways obstruction, oral administration of both clenbuterol (40 microgram) and salbutamol (4 mg) caused significantly greater increased in peak expiratory flow rate (P...
Kaydedildi:
| Yayımlandı: | Thorax |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
1977
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC470819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/341407/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.32.6.717 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|